Global Ophthalmology Therapeutics Market 2025-2029
Description
Ophthalmology Therapeutics Market 2025-2029
The ophthalmology therapeutics market is forecasted to grow by USD 25.3 bn during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-vegf inhibitors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's ophthalmology therapeutics market is segmented as below:
By Type
The report on the ophthalmology therapeutics market covers the following areas:
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
The ophthalmology therapeutics market is forecasted to grow by USD 25.3 bn during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-vegf inhibitors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's ophthalmology therapeutics market is segmented as below:
By Type
- Prescription drugs
- OTC drugs
- Retinal disorder therapeutics
- Glaucoma therapeutics
- Dry eye disease therapeutics
- Eye infections and inflammation therapeutics
- Others
- Anti-VEGF
- Anti-inflammatory
- Anti-glaucoma
- Anti-infectives
- Others
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the ophthalmology therapeutics market covers the following areas:
- Ophthalmology Therapeutics Market sizing
- Ophthalmology Therapeutics Market forecast
- Ophthalmology Therapeutics Market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
232 Pages
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
- Value chain analysis
- 4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
- 5 Historic Market Size
- 5.1 Global Ophthalmology Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Ophthalmology Therapeutics Market 2019 - 2023 ($ billion)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- 5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- 5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
- 6 Qualitative Analysis
- 6.1 The AI impact on Global Ophthalmology Therapeutics Market
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
- 8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Prescription drugs - Market size and forecast 2024-2029
- Chart on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on Prescription drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%)
- 8.4 OTC drugs - Market size and forecast 2024-2029
- Chart on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on OTC drugs - Year-over-year growth 2024-2029 (%)
- Data Table on OTC drugs - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
- 9 Market Segmentation by Product
- 9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 9.3 Retinal disorder therapeutics - Market size and forecast 2024-2029
- Chart on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
- 9.4 Glaucoma therapeutics - Market size and forecast 2024-2029
- Chart on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
- 9.5 Dry eye disease therapeutics - Market size and forecast 2024-2029
- Chart on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
- 9.6 Eye infections and inflammation therapeutics - Market size and forecast 2024-2029
- Chart on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
- 9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
- 10 Market Segmentation by Drug Class
- 10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 10.3 Anti-VEGF - Market size and forecast 2024-2029
- Chart on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-VEGF - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-VEGF - Year-over-year growth 2024-2029 (%)
- 10.4 Anti-inflammatory - Market size and forecast 2024-2029
- Chart on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
- 10.5 Anti-glaucoma - Market size and forecast 2024-2029
- Chart on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
- 10.6 Anti-infectives - Market size and forecast 2024-2029
- Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
- 10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ billion)
- Data Table on Market opportunity by Drug Class ($ billion)
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.13 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
- 13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
- 15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 15.5 Aldeyra Therapeutics Inc
- Aldeyra Therapeutics Inc - Overview
- Aldeyra Therapeutics Inc - Product / Service
- Aldeyra Therapeutics Inc - Key offerings
- SWOT
- 15.6 Apellis Pharmaceuticals Inc.
- Apellis Pharmaceuticals Inc. - Overview
- Apellis Pharmaceuticals Inc. - Product / Service
- Apellis Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.7 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- 15.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.10 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.11 Ocular Therapeutix Inc
- Ocular Therapeutix Inc - Overview
- Ocular Therapeutix Inc - Product / Service
- Ocular Therapeutix Inc - Key offerings
- SWOT
- 15.12 Otsuka Pharmaceutical Co Ltd.
- Otsuka Pharmaceutical Co Ltd. - Overview
- Otsuka Pharmaceutical Co Ltd. - Product / Service
- Otsuka Pharmaceutical Co Ltd. - Key offerings
- SWOT
- 15.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 15.14 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.15 Santen Pharmaceutical Co. Ltd.
- Santen Pharmaceutical Co. Ltd. - Overview
- Santen Pharmaceutical Co. Ltd. - Product / Service
- Santen Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- 15.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 15.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
- 15.18 Visufarma
- Visufarma - Overview
- Visufarma - Product / Service
- Visufarma - Key offerings
- SWOT
- 16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Type
- Exhibits6: Executive Summary - Chart on Market Segmentation by Product
- Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
- Exhibits8: Executive Summary - Chart on Incremental Growth
- Exhibits9: Executive Summary - Data Table on Incremental Growth
- Exhibits10: Executive Summary - Chart on Company Market Positioning
- Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits12: Overview on criticality of inputs and factors of differentiation
- Exhibits13: Overview on factors of disruption
- Exhibits14: Impact of drivers and challenges in 2024 and 2029
- Exhibits15: Parent Market
- Exhibits16: Data Table on - Parent Market
- Exhibits17: Market characteristics analysis
- Exhibits18: Value chain analysis
- Exhibits19: Offerings of companies included in the market definition
- Exhibits20: Market segments
- Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
- Exhibits25: Historic Market Size - Data Table on Global Ophthalmology Therapeutics Market 2019 - 2023 ($ billion)
- Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
- Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
- Exhibits31: Five forces analysis - Comparison between 2024 and 2029
- Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
- Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
- Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
- Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
- Exhibits37: Chart on Market condition - Five forces 2024 and 2029
- Exhibits38: Chart on Type - Market share 2024-2029 (%)
- Exhibits39: Data Table on Type - Market share 2024-2029 (%)
- Exhibits40: Chart on Comparison by Type
- Exhibits41: Data Table on Comparison by Type
- Exhibits42: Chart on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Exhibits43: Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ billion)
- Exhibits44: Chart on Prescription drugs - Year-over-year growth 2024-2029 (%)
- Exhibits45: Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%)
- Exhibits46: Chart on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Exhibits47: Data Table on OTC drugs - Market size and forecast 2024-2029 ($ billion)
- Exhibits48: Chart on OTC drugs - Year-over-year growth 2024-2029 (%)
- Exhibits49: Data Table on OTC drugs - Year-over-year growth 2024-2029 (%)
- Exhibits50: Market opportunity by Type ($ billion)
- Exhibits51: Data Table on Market opportunity by Type ($ billion)
- Exhibits52: Chart on Product - Market share 2024-2029 (%)
- Exhibits53: Data Table on Product - Market share 2024-2029 (%)
- Exhibits54: Chart on Comparison by Product
- Exhibits55: Data Table on Comparison by Product
- Exhibits56: Chart on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits57: Data Table on Retinal disorder therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits58: Chart on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits59: Data Table on Retinal disorder therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits60: Chart on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits61: Data Table on Glaucoma therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits62: Chart on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits63: Data Table on Glaucoma therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits64: Chart on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits65: Data Table on Dry eye disease therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits66: Chart on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits67: Data Table on Dry eye disease therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits68: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits69: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2024-2029 ($ billion)
- Exhibits70: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits71: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2024-2029 (%)
- Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%)
- Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%)
- Exhibits76: Market opportunity by Product ($ billion)
- Exhibits77: Data Table on Market opportunity by Product ($ billion)
- Exhibits78: Chart on Drug Class - Market share 2024-2029 (%)
- Exhibits79: Data Table on Drug Class - Market share 2024-2029 (%)
- Exhibits80: Chart on Comparison by Drug Class
- Exhibits81: Data Table on Comparison by Drug Class
- Exhibits82: Chart on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Exhibits83: Data Table on Anti-VEGF - Market size and forecast 2024-2029 ($ billion)
- Exhibits84: Chart on Anti-VEGF - Year-over-year growth 2024-2029 (%)
- Exhibits85: Data Table on Anti-VEGF - Year-over-year growth 2024-2029 (%)
- Exhibits86: Chart on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Exhibits87: Data Table on Anti-inflammatory - Market size and forecast 2024-2029 ($ billion)
- Exhibits88: Chart on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
- Exhibits89: Data Table on Anti-inflammatory - Year-over-year growth 2024-2029 (%)
- Exhibits90: Chart on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Exhibits91: Data Table on Anti-glaucoma - Market size and forecast 2024-2029 ($ billion)
- Exhibits92: Chart on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
- Exhibits93: Data Table on Anti-glaucoma - Year-over-year growth 2024-2029 (%)
- Exhibits94: Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Exhibits95: Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
- Exhibits96: Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Exhibits97: Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Exhibits98: Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Exhibits99: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Exhibits100: Chart on Others - Year-over-year growth 2024-2029 (%)
- Exhibits101: Data Table on Others - Year-over-year growth 2024-2029 (%)
- Exhibits102: Market opportunity by Drug Class ($ billion)
- Exhibits103: Data Table on Market opportunity by Drug Class ($ billion)
- Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
- Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
- Exhibits107: Chart on Geographic comparison
- Exhibits108: Data Table on Geographic comparison
- Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
- Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
- Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
- Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
- Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ billion)
- Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
- Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
- Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
- Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
- Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
- Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
- Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%)
- Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ billion)
- Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
